Rivaroxyban-R-isomer is the enantiomeric counterpart of the anticoagulant Rivaroxaban, featuring a chiral center at the pyrazole-fused tetrahydrothiazole core. Its structure incorporates a benzylsulfonamide moiety, a 5-chlorophenyl ring, and a pyrazole-linked tetrahydrothiazole with R-configuration. This impurity arises from partial enantioselective synthesis or racemization during Rivaroxaban production. The compound retains the parent drugโs key pharmacophoric elements but exhibits distinct stereochemical interactions. It serves as a critical reference standard for chiral HPLC method validation in API purity profiling.
On Request| Std | Catalog # | Quantity | Price |
|---|---|---|---|
| USP | 1604541 โ | 20 mg | USD 830.00 |
C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl
InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m1/s1
KGFYHTZWPPHNLQ-CQSZACIVSA-N